Format

Send to:

Choose Destination
See comment in PubMed Commons below
Proc SPIE. 2011 Mar 4;7965. doi: 10.1117/12.891720.

Quantifying receptor density in vivo using a dual-probe approach with fluorescence molecular imaging.

Author information

  • 1Thayer School of Engineering at Dartmouth, 8000 Cummings Hall, New Hampshire, NH, USA 03755.

Abstract

Molecular imaging technologies are advancing rapidly and optical techniques in particular are set to play a large role in preclinical pharmaceutical testing. These approaches, however, are generally unable to quantify the level of expression of imaging probe reporters. In this study a novel method of quantification is presented using dual-probe fluorescence imaging, where an endothelial growth factor receptor (EGFR) fluorescent probe was paired with a non-targeted probe before being injected, and tracer kinetic compartmental modeling was used to determine EGFR expression in a region of interest from the uptake curves of the two drugs in that region. The approach was tested out in a simulation experiment and then applied in an in vivo study in one mouse to investigate EGFR expression in various tissue types (pancreas, pancreas tumor, and leg). The binding potentials (a unitless correlate of target availability) of EGFR expression in the various tissue types were 8.57, 25.64, and 0.11 for the pancreas, pancreas tumor, respectively. For the pancreas and leg, these results correlate well with expected levels of EGFR expression, with the pancreas demonstrating a much higher expression than the skin and also as expected, the tumor expressed much more EGFR than either healthy tissue.

KEYWORDS:

dual probe imaging; fluorescence molecular imaging; tracer kinetic modeling

PMID:
24379938
[PubMed]
PMCID:
PMC3874279
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk